Lacosamide Injection
Product Images NDC 31722-203

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 31722-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Aspiro (Aspiro)

Aspiro (Aspiro)
FDA Label Image
Camberlogo (Camberlogo)
FDA Label Image

Lacosamide-carton-label-10-mg-ml (Lacosamide Carton Label 10 mg mL)

Lacosamide-carton-label-10-mg-ml (Lacosamide Carton Label 10 mg mL)
This is a description for Lacosamide Injection, a USP (United States Pharmacopeia) drug used only for intravenous use. The manufacturer is not clear, but the medication comes in 10 x 20 mL single-dose vials. The text also provides contact information and a medication guide to be provided separately to each patient by a pharmacist.*
FDA Label Image

Lacosamide-figure-1 (Lacosamide Figure 1)

Lacosamide-figure-1 (Lacosamide Figure 1)
This text appears to be a table showing median percentage changes in Baseline after treatment with placebo and Lacosamide. The percentage changes are sorted based on the dosage (in mg/day) of Lacosamide administered. The number of participants (N) in each dosage group is also provided.*
FDA Label Image

Lacosamide-figure-2 (Lacosamide Figure 2)

Lacosamide-figure-2 (Lacosamide Figure 2)
FDA Label Image

Lacosamide-structure (Lacosamide Structure)

Lacosamide-structure (Lacosamide Structure)
FDA Label Image

Lacosamide-vial-label-10-mg-ml (Lacosamide Vial Label 10 mg mL)

Lacosamide-vial-label-10-mg-ml (Lacosamide Vial Label 10 mg mL)
This text describes a medication called Lacosamide in Injection form with a concentration of 200 mg/20 mL (10 mg/mL). It is controlled and meant for intravenous use only. The package insert should be referred to for usual dosage information. The remaining medication should be discarded. It should be stored between 20°C to 25°C, with permissible excursions between 15°C to 30°C. Contact information and manufacturing details are provided along with important details such as lot and batch codes. A medication guide is available at the given website.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.